Skip to main content

In addition to the novel CAR-T therapies offered through our clinical trials program, our care team can provide our patients the following FDA-approved therapies:

Kymriah for acute lymphoblastic leukemia or non-Hodgkin lymphoma

Yescarta for large B-cell lymphoma and follicular lymphoma

Tecartus for mantle cell lymphoma

Breyanzi for large B-cell lymphoma

Abecma for relapsed or refractory multiple myeloma


Want to learn more about CAR-T clinical trials at UNC Lineberger?

Contact Us